Syndax Pharmaceuticals
SNDX
SNDX
71 hedge funds and large institutions have $160M invested in Syndax Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
3% more funds holding
Funds holding: 69 → 71 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.5% less ownership
Funds ownership: 67.88% → 63.37% (-4.5%)
Holders
71
Holding in Top 10
1
Calls
$929K
Puts
$621K
Top Buyers
| 1 | +$1.71M | |
| 2 | +$1.09M | |
| 3 | +$1.02M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$760K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$752K |
Top Sellers
| 1 | -$2.08M | |
| 2 | -$753K | |
| 3 | -$727K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$698K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$661K |